Disruption of the interferon-gamma axis limits chimeric antigen receptor T cell efficacy against acute…

Transcriptome Analysis Identifies a Myeloid-Like Signature in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Poor Response to CD19 Chimeric Antigen Receptor T Cell Therapy.
Shisen Wang, Wenbing Liu, Ying Wang +10
Cancer medicine1 Oct 2026Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
DEVELOPMENT OF A CD33 P67 EPITOPE EDITING PLATFORM TOWARD HEMATOPOIETIC STEM CELL SHIELDING IN ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ACUTE MYELOID LEUKEMIA
Maria Fernanda MADRID MENDOZA, Maria Luiza SALUSTIANO-BANDEIRA, César Alexander ORTIZ ROJAS +5
Hematology, Transfusion and Cell Therapy23 Oct 2026Peer-reviewedCC BYFull textOncologyDOAJ
Lipid-based mRNA chimeric antigen receptor T cells for enhanced in vitro antitumor activity
Haixia Gao, Yuan Fang, Zhidan Tian +6
iScience1 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossrefEurope PMC
Temporal dynamics of immune effector cell‐associated haematotoxicity: Linking early and late cytopenias after chimeric antigen receptor T cells
Malvina Bichon, Roch Houot, Mana Alshehri +3
British Journal of Haematology18 Sep 2026Peer-reviewedCC BY 4.0Full textGeneral biology OncologyHAL
197 Chimeric antigen receptor T-cell therapy in glioblastoma: a systematic review and meta analysis of early phase clinical trials with GRADE assessment
Ahmed Elhadi, Vincent Yuan, Zaid Hasan +1
Journal for ImmunoTherapy of Cancer7 Nov 2026Peer-reviewedCC BYFull textOncologyDOAJ

Cite

BibTeX

@misc{murren2026disruption,
  title = {{Disruption of the interferon-gamma axis limits chimeric antigen receptor T cell efficacy against acute myeloid leukemia}},
  author = {N. Murren and I. King and L. Mahoney and J. Roy and O. A. Kletzien and M. Collins and S. Geffe and L. Kalcheim and R. Richards},
  howpublished = {bioRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.28.747900},
  url = {https://www.biorxiv.org/content/10.64898/2026.08.28.747900v1},
}

RIS

TY  - UNPB
TI  - Disruption of the interferon-gamma axis limits chimeric antigen receptor T cell efficacy against acute myeloid leukemia
AU  - N. Murren
AU  - I. King
AU  - L. Mahoney
AU  - J. Roy
AU  - O. A. Kletzien
AU  - M. Collins
AU  - S. Geffe
AU  - L. Kalcheim
AU  - R. Richards
PY  - 2026
DA  - 2026/08/28
PB  - bioRxiv
DO  - 10.64898/2026.08.28.747900
UR  - https://www.biorxiv.org/content/10.64898/2026.08.28.747900v1
ER  -

Related

Cite